Kenvue CEO Thibaut Mongon at the New York Stock Exchange for its initial public offering, May 4, 2023.Kenvue settled its proxy fight with activist Starboard Value, sources tell CNBC's David Faber.Starboard's Jeff Smith will join the board of the Johnson & Johnson spinoff, along with two new independent directors not affiliated with the activist, sources said.Kenvue is the maker of iconic brands familiar to both investors and the broader public, such as Aveeno, Band-Aid, Listerine, Neutrogena, Tylenol and J& ...